29
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Detection of Epstein-Barr Virus DNA in Hepatocellular Carcinoma Tissues from Hepatitis C-positive Patients

Pages 981-984 | Published online: 08 Jul 2009

References

  • Paterlini P, Bréchot C. The detection of hepatitis B virus in HBAG negative individuals with primary liver cancer. Dig Dis Sci 1991;36:1122–9.
  • Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:6547–9.
  • Kasai Y, Takeda S, Takagi H. Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis. Semin Surg Oncol 1996;12:155–9.
  • Uchida T, Shikata T, Tanaka E, Kiyosawa K. Immunoperoxidase staining of hepatitis C virus in formalin-fixed, paraffin embedded needle liver biopsies. Virchows Arch 1994;424: 465–9.
  • Koike K, Kobayashi M, Gondo M, Hayashi I, Osuga T, Takada S. Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients. J Med Virol 1998;54:249–55.
  • Paterlini P, Gerken G, Nakajima E, Terre S, D’Errico A, Grigioni W, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990;323:80–5.
  • Paterlini P, Poussin K, Kew M, Franco D, Bréchot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 1995;21:313–21.
  • Sugawara Y, Makuuchi M, Takada K. Detection of hepatitis B virus (HBV) DNA in the tissues of hepatocellular carcinomas related to hepatitis C virus that are negative for HBV surface antigen. Scand J Gastroenterol 1999;34:934–8.
  • Epstein MA, Achong BG. Introductory considerations. In: Epstein MA, Achong BG, editors. The Epstein-Barr virus: recent advances. London: Heinemann Medical Books; 1986. p. 1–11.
  • Markin RS. Manifestations of Epstein-Barr virus-associated disorders in liver. Liver 1994;14:1–13.
  • Sugawara Y, Mizugaki Y, Uchida T, Torii T, Imai S, Shinozaki F, et al. Detection of EBV in hepatocellular carcinoma tissue: a novel EBV latency characterized by absence of EBER expression. Virology 1999;256:196–202.
  • Sugawara Y, Kato N, Shimotohno K, Makuuchi M, Takada K. Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1. EMBO J 1999;18: 5755–60.
  • Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999;134:984–92.
  • Sambrook J, Fritsch EF, Maniatis T Molecular cloning: a laboratory manual. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1989.
  • International Union Against Cancer. Liver. In: Sobin LH, editor. TNM classification of malignant tumours. 5th ed. New York: A John Wiley & Sons Inc. Publication; 1997. p. 74–7.
  • Imai S, Usui S, Sugiura M, Osato T, Sato T, Tsutsumi H, et al. Epstein-Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infections. J Med Virol 1993;40:278–84.
  • Sternas L, Middleton T, Sugden B. The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus DNA molecules per cell among different clones of EBV-immmortalized cells. J Virol 1990;64: 2407–10.
  • Klein G, Lindahl T, Jondal M, Leibold W, Menézes J, Nilsson K, et al. Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci USA 1974;71:3283–6.
  • Saito I, Servenius B, Compton T, Fox RI. Detection of Epstein Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren’s syndrome. J Exp Med 1989;169:2191–8.
  • Wagner HJ, Bein G, Bitsch A, Kirchner H. Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J Clin Microbiol 1992;30:2826–9.
  • Morshed SA, Nishioka M, Saito I, Komiyama K, Moro I. Increased expression of Epstein-Barr virus in primary biliary cirrhosis patients. Gastroenterol Jpn 1992;27:751–8.
  • Rickinson AB, Kieff E. Epstein-Barr virus. In: Fields BN, Knipe DM, editors. Fields virology. 3rd ed. Philadelphia: Lippincott Raven Publishers; 1996. p. 2397–446.
  • Delarco J, Todaro G. Growth factor from murine sarcoma virus transformed cells. Proc Natl Acad Sci USA 1987;75:4001–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.